Stock Price
6.10
Daily Change
-1.03 -14.45%
Monthly
-19.74%
Yearly
39.59%
Q2 Forecast
5.99

Silence Therapeutics reported $131.44M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
AstraZeneca USD 114.02B 59M Mar/2026
Autolus Therapeutics Ltd USD 527.06M 62M Mar/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Novartis USD 118.53B 7.58B Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
Silence Therapeutics USD 131.44M 15.35M Dec/2025